Publications by authors named "Unaiza Zaman"

Article Synopsis
  • Non-small cell lung cancer (NSCLC) is the most common lung cancer type, responsible for a majority of cancer deaths globally, and advancements in treatments, especially targeted therapies like osimertinib, have improved management options.
  • Osimertinib, a third-generation tyrosine kinase inhibitor, effectively targets specific mutations in the EGFR gene, including rare mutations, as exemplified by a 64-year-old woman whose unique exon 19 mutation responded well to the drug, leading to 26 months of disease control.
  • The study highlights the limited research available for rare EGFR mutations and emphasizes the need for further prospective studies to better understand treatment responses and ensure safe and effective therapies for this patient group.
View Article and Find Full Text PDF

Background: For the initial staging of breast cancer (BC), 18FDG PET/CT is recommended by professional guidelines in stage III (except T3N1) and inflammatory BC (T4d) and optional when conventional imaging is equivocal or suspicious. However, growing evidence also supports its role in the staging of intermediate-risk groups (IIA, IIB, T3N1 of IA). This study aimed to compare the impact of 18FDG PET/CT with conventional imaging (CT-chest+abdomen+pelvis and bone scan; CT-CAP+BS) in staging, cost-effectiveness, and radiation exposure in the initial staging of BC.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to determine the prognostic value of imaging and tumor markers in predicting progression-free survival (PFS) in patients with untreated pancreatic cancer using baseline PET/CT scans.
  • Conducted in Pakistan, the research included 68 pancreatic cancer patients from 2017 to 2020, analyzing their treatment outcomes based on their initial imaging and tumor characteristics.
  • Results indicated a median PFS of 18 months, with significant predictors for disease progression identified as Stage IV cancer and higher levels of certain markers (SUVmax >5.3 and CA 19-9 >197 U/ml).
View Article and Find Full Text PDF

Background:  In the current era vaccine-associated lymphadenopathy (VAL) is not an uncommon presentation on 18F-FDG PET/CT examinations in patients inoculated with Coronavirus disease 2019 (COVID-19) vaccination. In this study, we are presenting data of VAL on 18F-FDG PET/CT regarding its prevalence, temporal response to vaccination and imaging characteristics of VAL.

Methods: Seventy-eight (78) consecutive vaccinated breast cancer (BC) patients who had 18FDG PET/CT were retrospectively analyzed.

View Article and Find Full Text PDF

Systemic mastocytosis (SM) is a relatively rare heterogeneous group of disorders characterized by uncontrolled proliferation and accumulation of clonal mast cells in one or more organs. Indolent SM is the most common variety. Less common variety is aggressive systemic mastocytosis (aSM) type with or without associated hematological neopalsm (AHN).

View Article and Find Full Text PDF

 The purpose fo this prospective study was to find the impact of primary tumor size (Ts), standardized uptake values (SUVmax) of primary tumor, and the most avid neck node on disease recurrence in patients with head and neck oropharyngeal squamous cell carcinoma (HNOP-SCC).  We included patients with HNOP-SCC (without distant metastasis-M0 disease) who had pre- and post-treatment F-18 fluorodeoxyglucose positron emission tomography/computed tomography ( FDG PET/CT) using strict standardized imaging protocol from 2017 to 2019. Based on follow-up ( FDG PET/CT) findings, patients were categorized as disease free (no or minimal FDG uptake ≤ background over surgical bed and no distant metastasis) and disease recurrence ( FDG uptake > background over surgical bed with or without nodal and/or distant metastasis).

View Article and Find Full Text PDF
Article Synopsis
  • Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT) is a rare and serious skin cancer that can be difficult to diagnose due to its varied skin presentations.
  • A case study discusses a 66-year-old woman with a medical history who developed abscess-like lesions on her buttocks, which were ultimately diagnosed as PCDLBCL-LT after biopsies.
  • She underwent a successful treatment regimen (R-CHOP) followed by radiation therapy, leading to complete remission, and she remained in remission for several years after treatment.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigated progression-free survival (PFS) and recurrence predictors in patients with diffuse large B-cell lymphoma (DLBCL) who showed a negative interim PET/CT scan, with a focus on a group that achieved a complete metabolic response (CMR).
  • - Conducted from December 2015 to February 2020, it included 185 DLBCL patients, finding that 66% maintained sustained CMR while 34% experienced recurrence, with a median PFS of 34 months.
  • - The analysis indicated that only the highest standardized uptake value (SUVmax) from the initial scan, specifically values over 22.6, significantly predicted disease recurrence, emphasizing the need for ongoing monitoring for at-risk
View Article and Find Full Text PDF
Article Synopsis
  • Carcinoma of unknown primary (CUP) is a condition where tumor metastases are present but the primary source is unidentified, and this study aimed to assess the detection effectiveness of FDG PET/CT scans in such patients.
  • Conducted at Aga Khan University Hospital, the study examined 46 patients with CUP, using FDG PET/CT scans to locate potential primary tumor sites, followed by biopsies of those areas.
  • The results indicated that FDG PET/CT had a detection rate of 57%, sensitivity of 68%, and positive predictive value (PPV) of 76%, proving to be a useful tool for identifying the primary tumor in patients with CUP.
View Article and Find Full Text PDF

Background: Precise staging of esophageal cancer (EC) is important for selection of optimal treatment option and prognostication. Aim of this study was to assess the role of 18FDG PET/CT in staging and response evaluation to neoadjuvant chemoradiation (nCR) in EC patients using standardized imaging protocol. Material and methods: This prospective study was conducted at PET/CT Section of Department of Radiology, Aga Khan University Hospital Karachi, Pakistan from July 2017 till February 2018.

View Article and Find Full Text PDF
Article Synopsis
  • - This study examined the metabolic responses of lymphoma patients through PET/CT scans, focusing on standard imaging protocols and comparing results from baseline to interim scans taken during chemotherapy.
  • - Out of 112 patients, 97 were included, with a majority showing no significant demographic differences between those who responded well to treatment and those who didn’t.
  • - Results indicated that while overall predictors for metabolic response were not significant, a correlation was found specifically between baseline SUV (standardized uptake value) and tumor size in responders.
View Article and Find Full Text PDF

This prospective study was carried out to find the negative predictive value of various Duke Treadmill Scores (DTSs) in patients with normal myocardial perfusion imaging (MPI). This study was conducted from August 2012 to July 2015, and 603 patients having normal exercise MPIs were included. Patients were followed for 2 years for fatal myocardial infarction (FMI) and nonfatal myocardial infarction (NFMI).

View Article and Find Full Text PDF

Tumor thrombosis is a relatively uncommon complication of renal cell carcinoma (RCC), and its diagnosis has therapeutic and prognostic implication. Computerized tomography (CT) is the primary imaging modality for staging RCC, but it has low sensitivity to differentiate between tumor thrombus and bland or benign thrombus. 18-fluorodeoxyglucose positron emission tomography/CT (PET/CT) has a limited role in diagnosis and staging of RCC, but its diagnostic accuracy is considerably high for detection of metabolically active tumor thrombus.

View Article and Find Full Text PDF
Article Synopsis
  • * Current imaging methods for detecting prostate cancer metastasis have low sensitivity, making it difficult to accurately stage the disease or monitor recurrence after treatment.
  • * New Gallium-68 PSMA PET imaging shows higher diagnostic accuracy and is promising for both staging and treatment of prostate cancer, opening avenues for personalized therapeutic approaches.
View Article and Find Full Text PDF

For vasodilator stress, myocardial perfusion imaging (MPI) with at least 12-h caffeine abstinence is recommended, as it attenuates cardiovascular hyperemic response of adenosine and dipyridamole. However, many published conflicting results have shown no significant effect upon perfusion abnormalities in MPI performed without caffeine abstinence. The aim of this study was to compare the hemodynamic changes and negative predictive value (NPV) of normal MPIs with adenosine stress performed with or without caffeine abstinence.

View Article and Find Full Text PDF
Article Synopsis
  • Fluorodeoxyglucose (18FDG) PET/CT imaging is crucial in cancer management, but concerns about radiation exposure, especially in younger patients, prompted this study to evaluate the effective dose from these scans using updated guidelines.
  • The study involved 63 cancer patients and utilized a low dose, nonenhanced CT protocol while calculating effective radiation doses from both the 18FDG injection and the CT scans.
  • Results indicated that the median effective dose from the whole body PET/CT scan was 8.85 mSv, which is relatively low, reinforcing the need to follow dose-reducing practices in clinical settings.
View Article and Find Full Text PDF

Background: There is controversy about ablation efficacy of low or high doses of radioiodine-131 (RAI) in patients with differentiated thyroid cancers (DTC). The purpose of this prospective study was to determine efficacy of 30 mCi and 100 mCi of RAI to achieve successful ablation in patients with low to intermediate risk DTC.

Materials And Methods: This prospective cross sectional study was conducted from April 2013 to November 2015.

View Article and Find Full Text PDF

Background: Patients with differentiated thyroid cancers (DTC) who receive radioactive iodine-131 (RAI) are released from isolation when their dose rate is below the regulatory requirements. The purpose of this study was establish predicting factors for early release from the isolation facility after RAI administration in patients with DTC.

Materials And Methods: This was a prospective study which included 96 (58 females and 38 males) patients with DTC who had received RAI from April 2013 till August 2015.

View Article and Find Full Text PDF

Purpose: The purpose was to find out the efficacy of fixed 15 mCi radioactive iodine-131 (RAI) dose and predictive values of various factors for inducing hypothyroidism in Graves' disease (GD).

Materials And Methods: Retrospective study conducted from January 2012 till August 2014. Patients with GD who had a technetium-99m thyroid scan, thyroid antibodies, received fixed 15 mCi RAI and did follow endocrine clinics for at least 6 months were selected.

View Article and Find Full Text PDF

In oncology various imaging modalities play a crucial role in diagnosis, staging, restaging, treatment monitoring and follow up of various cancers. Stand-alone morphological imaging like computerized tomography (CT) and magnetic resonance imaging (MRI) provide a high magnitude of anatomical details about the tumor but are relatively dumb about tumor physiology. Stand-alone functional imaging like positron emission tomography (PET) and single photon emission tomography (SPECT) are rich in functional information but provide little insight into tumor morphology.

View Article and Find Full Text PDF

Background: To assess the frequency of normal and abnormal myocardial perfusion imaging (MPI) in a consecutive cohort of patients from Pakistan over a period of 8.5 years.

Material And Methods: We assessed 9170 patients who had undergone stress-rest MPI between January 2004 and June 2013.

View Article and Find Full Text PDF

Radionuclide bone imaging is one of the most commonly performed nuclear medicine procedure around the world and characterized by its high sensitivity and relatively low specificity. False positive findings on a bone scan are very common; however, dense uptake over unilateral ossified anterior longitudinal ligament appearing as single thyroid lobe on a bone scan has not been described in the literature.

View Article and Find Full Text PDF

Positron emission tomography (PET) as the functional component of current hybrid imaging (like PET/ CT or PET/MRI) seems to dominate the horizon of medical imaging in coming decades. 18Flourodeoxyglucose (18FDG) is the most commonly used probe in oncology and also in cardiology and neurology around the globe. However, the major capital cost and exorbitant running expenditure of low to medium energy cyclotrons (about 20 MeV) and radiochemistry units are the seminal reasons of low number of cyclotrons but mushroom growth pattern of PET scanners.

View Article and Find Full Text PDF

Background: To determine the predictive value of the baseline stimulated thyroglobulin (STg) level for ablation outcome in patients undergoing adjuvant remnant radioiodine ablation (RRA) for differentiated thyroid carcinoma (DTC).

Materials And Methods: This retrospective study accrued 64 patients (23 male and 41 female; mean age of 40±14 years) who had total thyroidectomy followed by RRA for DTC from January 2012 till April 2014. Patients with positive anti-Tg antibodies and distant metastasis on post-ablative whole body iodine scans (TWBIS) were excluded.

View Article and Find Full Text PDF